Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Controversies in Drug Substitution
Link ID 577
Title Controversies in Drug Substitution
Url http://www.medscape.com/viewarticle/563959?src=rss
Description When is it appropriate for pharmacists to substitute less costly equivalent drugs for prescribed medications?
Medscape Pharmacists
Category Articles > Business of Medicine
Keywords
Date Nov 9, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Cialis, Viagra Labels to Note Amnesia
  Rare reports of transient global amnesia have been added to the Cialis and Viagra labels; the condition is already on the Levitra label. WebMD Health News
Category:   Articles > Business of Medicine


2. Transitioning Internationally Educated Nurses for Success: A Model Program
  Learn about transition programs that integrate internationally educated nurses to practice in the United States.
OJIN: The Online Journal of Issues in Nursing
Category:   Articles > Business of Medicine


3. Bayer Stops Late-Stage Nexavar Trial
  Bayer HealthCare, a U.S. based unit of Bayer AG, said it stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer, after an independent data monitoring committee concluded that the study would not meet its main goal of improved overall survival. Reuters Health Information
Category:   Articles > Business of Medicine


4. Pharmacogenetic Tests Lack Regulatory Oversight, Critics Say
  A new critique of the system says that misleading claims and lack of validation may endanger public attitudes toward personalized medicine. Medscape Medical News
Category:   Articles > Business of Medicine


5. U.S. Democrats Object to Plan on Drug Label Changes
  Eight U.S. congressional Democrats urged the U.S. Food and Drug Administration on Wednesday to reconsider a plan that the lawmakers said would shield companies from liability rather than protect patients. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS